Advantage of recombinant von Willebrand factor for peri-operative management in paediatric acquired von Willebrand syndrome

被引：6
|
作者：
Weyand, A. C. [1 ]
Jesudas, R. [2 ]
Pipe, S. W. [1 ,3 ]
机构：
[1] Univ Michigan, Dept Paediat & Communicable Dis, Ann Arbor, MI 48109 USA
[2] Bleeding & Clotting Disorders Inst, Peoria, IL USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
来源：
HAEMOPHILIA | 2018年 / 24卷 / 03期
关键词：
FACTOR-VIII; DISEASE; RISK;
D O I：
10.1111/hae.13436
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E120 / E121
页数：2
相关论文
共 50 条
  • [1] Paediatric acquired von Willebrand syndrome
    Will, A
    HAEMOPHILIA, 2006, 12 (03) : 287 - 288
  • [2] Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome
    Casonato, A
    Pontara, E
    Doria, A
    Bertomoro, A
    Cattini, MG
    Gambari, PF
    Girolami, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (04) : 899 - 904
  • [3] Management of acquired von Willebrand syndrome
    Charlebois, Janie
    Rivard, Georges-Etienne
    St-Louis, Jean
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (06) : 721 - 723
  • [4] Acquired von Willebrand syndrome secondary to a functional defect of von Willebrand factor
    Galvez, K. M.
    Combariza, J. F.
    Gomez, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1180 - 1180
  • [5] Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status
    Lee, Adrienne
    Sinclair, Gary
    Valentine, Karen
    James, Paula
    Poon, Man-Chiu
    BLOOD, 2014, 124 (05) : E1 - E3
  • [6] Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome
    Stufano, Francesca
    Boscarino, Marco
    Bucciarelli, Paolo
    Baronciani, Luciano
    Maino, Alberto
    Cozzi, Giovanna
    Peyvandi, Flora
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (01): : 36 - 42
  • [7] Treatment of acquired von Willebrand syndrome with von Willebrand factor-containing concentrate
    Tiede, A.
    Priesack, J. .
    Werwitzke, S.
    Trummer, A.
    Ganser, A.
    Budde, U.
    HAEMOPHILIA, 2008, 14 : 1 - 2
  • [8] A candidate mechanism for von Willebrand factor abnormalities in a patient with acquired von Willebrand syndrome
    Haj, MA
    Murch, N
    Bowen, DJ
    Collin, PW
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 43 - 43
  • [9] Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures
    Desprez, Dominique
    Pierre, Lea
    Hittinger, Xavier
    Babuty, Antoine
    Sattler, Laurent
    Ternisien, Catherine
    Herb, Agathe
    Trossaert, Marc
    Gerout, Anne-Cecile
    Fouassier, Marc
    Wimmer, Jordan
    Feugeas, Olivier
    Drillaud, Nicolas
    HAEMOPHILIA, 2024, 30 (06) : 1341 - 1347
  • [10] Use of recombinant Von Willebrand factor during transcatheter aortic valve replacement in a patient with acquired von Willebrand syndrome
    Sattler, Laurent
    Feugeas, Olivier
    Crimizade, Ulun
    Hess, Sebastien
    Grunebaum, Lelia
    Desprez, Dominique
    TRANSFUSION MEDICINE, 2021, 31 (02) : 142 - 144
12345